TP53 and colorectal carcinoma: We hypothesize miR-532-3p to act as a vital upstream inhibitor of the Wnt/β-catenin signaling via the ETS1/TGM2 axis and propose its involvement in inducing p53 activation and restraining aggressive phenotypes of CRC.